SCHEMBL7367306

SCHEMBL7367306

CCOC(=O)CCCOc1ccc(C=O)cc1OC

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FDPS P14324 2/20 0.67
ALDH1A1 P00352 9/20 0.60
CYP2C9 P11712 2/20 0.59
NPSR1 Q6W5P4 2/20 0.59
NPC1 O15118 1/20 0.59
RAB9A P51151 1/20 0.59
MAPT P10636 6/20 0.58
SMN1; SMN2 Q16637 5/20 0.58
HPGD P15428 3/20 0.58
CYP1A2 P05177 1/20 0.58
HSP90AA1 P07900 1/20 0.58
CYP2C19 P33261 1/20 0.58
LMNA P02545 4/20 0.55
HTT P42858 2/20 0.55
TSHR P16473 1/20 0.54
ADORA2A P29274 1/20 0.52
POLB P06746 1/20 0.52
BCHE P06276 1/20 0.52
ACHE P22303 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18554126 0.95 FDPS (0.63) FDPSALDH1A1CYP2C9NPSR1NPC1
SCHEMBL17821696 0.95 FDPS (0.58) FDPSALDH1A1CYP2C9NPSR1NPC1
SCHEMBL3934768 0.89 FDPS (0.70) FDPSALDH1A1CYP2C9NPSR1NPC1
SCHEMBL18574520 0.88 FDPS (0.60) FDPSALDH1A1CYP2C9NPSR1NPC1
SCHEMBL3788224 0.85 ALDH1A1 (0.76) FDPSALDH1A1CYP2C9NPSR1NPC1
SCHEMBL2559267 0.85 FDPS (0.72) FDPSALDH1A1CYP2C9NPSR1NPC1
SCHEMBL27118587 0.85 FDPS (0.72) FDPSALDH1A1CYP2C9NPSR1NPC1
SCHEMBL2654920 0.84 FDPS (0.44) FDPSALDH1A1CYP2C9NPSR1NPC1
SCHEMBL8886451 0.84 ALDH1A1 (0.50) FDPSALDH1A1CYP1A2CYP2C19
SCHEMBL9442186 0.83 FDPS (0.90) FDPSALDH1A1CYP2C9NPSR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230137943-A1 PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS THE UNIVERSITY OF CHICAGO 2023-05-04 US disclosed
US-20230137943-A1 PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS THE UNIVERSITY OF CHICAGO 2023-05-04 US disclosed
EP-3386985-A1 PBD ANTIBACTERIAL AGENTS Kings College London (GB) 2018-10-17 EP disclosed
WO-2017098257-A1 PBD ANTIBACTERIAL AGENTS KING'S COLLEGE LONDON (GB) 2017-06-15 WO disclosed
US-20150104427-A1 ENZYME-ASSISTED SPATIAL DECORATION OF BIOMATERIALS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-04-16 US disclosed
EP-0538384-A4 OXAMIDES SMITHKLINE BEECHAM CORP (US) 1995-04-12 EP disclosed
US-5393788-A Phenylalkyl oxamides SMITHKLINE BEECHAM CORPORATION (US) 1995-02-28 US disclosed
EP-0538384-A1 OXAMIDES SMITHKLINE BEECHAM CORPORATION (US) 1993-04-28 EP disclosed
WO-1992000968-A1 OXAMIDES SMITHKLINE BEECHAM CORPORATION (US) 1992-01-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230137943-A1 PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS PPIA, S100A4, S100A6 FDPS 2079/4885ALDH1A1 2889/4885CYP2C9 3446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.